Gambit New Orleans: October 16, 2012 by Gambit New Orleans - Issuu
Cancers | Announcements
Discovery of a Dihydroisoquinolinone Derivative (NVP-CGM097): A Highly Potent and Selective MDM2 Inhibitor Undergoing Phase 1 Clinical Trials in p53wt Tumors | Journal of Medicinal Chemistry